Prevalence of human papillomavirus in mobile tongue cancer with particular reference to young patients

Cancer Science

Volumn 103, Issue 2, 2012, Pages 161-168

  Kabeya, Masayuki ^a,b   Furuta, Reiko ^a   Kawabata, Kazuyoshi ^c   Takahashi, Sugata ^b   Ishikawa, Yuichi ^a  

^a CANCER INSTITUTE   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 2A; FRESH FROZEN PLASMA; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CARCINOGENESIS; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; ELECTROCHEMISTRY; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ISOTHERM; KERATINIZATION; MALE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TONGUE CANCER; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; TONGUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 84856497456     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.02149.x     Document Type: Article

References (62)

1. Jo S, Juhasz A, Zhang K et al. Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinoma treated in a prospective Phase II clinical trial. Anticancer Res 2009; 29: 1467-74.
2. Machado J, Reis PP, Zhang T et al. Low prevalence of human papillomavirus in oral cavity cacinomas. Head Neck Oncol 2010; 2: 6.
3. El-Mofty SK. Human papillomavirus (HPV) related carcinomas of the upper aerodigestive tract. Head Neck Pathol 2007; 1: 181-5.
4. Walboomers JM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-9.
5. Harper DM, Franco EL, Wheeler C et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomized controlled trial. Lancet 2004; 364: 1757-65.
6. Michel KB, zur Hausen H. HPV vaccine for all. Lancet 2009; 374: 268-70.
7. Paavonen J, Naud P, Salmeron J et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009; 374: 301-14.
8. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467-75.
9. D'Souza G, Kreimer AR, Viscidi R et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356: 1944-56.
10. Bouda M, Gorgoulis VG, Kastrinakis NG et al. "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol 2000; 13: 644-53.
11. Liang XH, Lewis J, Foote R, Smith D, Kademani D. Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience. J Oral Maxillofac Surg 2008; 66: 1875-80.
12. Matzow T, Boysen M, Kalantari M, Johansson B, Haqmar B. Low detection rate of HPV in oral and laryngeal carcinomas. Acta Oncol 1998; 37: 73-6.
13. Kansky AA, Poljak M, Seme K et al. Human papillomavirus DNA in oral squamous cell carcinomas and normal oral mucosa. Acta Virol 2003; 47: 11-6.
14. Siebers TJ, Merkx MA, Slootweg PJ, Melchers WJ, van Cleef P, de Wilde PC. No high-risk HPV detected in SCC of the oral tongue in the absolute absence of tobacco and alcohol: a case study of seven patients. Oral Maxillofac Surg 2008; 12: 185-8.
15. Premoli-de-Percoco G, Ramirez JL. High risk human papillomavirus in oral squamous carcinoma: evidence of risk factors in aVenezuelan rural population. Preliminary report. J Oral Pathol 2001; 30: 355-61.
16. Cruz IB, Snijders PJ, Steenbergen RD et al. Age-dependence of human papillomavirus DNA presence in oral squamous cell carcinomas. Eur J Cancer B Oral Oncol 1996; 32: 55-62.
17. Mork J, Lie AK, Glattre E et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 344: 1125-31.
18. Cao J, Zhang ZY, Patima, Zhang YX, Chen WT. Human papillomavirus infection and p53 alteration in oral squamous cell carcinoma. Chin J Dent Res 2000; 3: 44-9.
19. Dahlgren L, Dahlstrand HM, Lindquist D et al. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer 2004; 112: 1015-9.
20. INK4A genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas. Hum Pathol 2008; 39: 452-8.
21. Salem A. Dismissing links between HPV and aggressive tongue cancer in young patients. Ann Oncol 2010; 21: 13-7.
22. Chitapanarux I, Lorvidhaya V, Sittitrai P et al. Oral cavity cancers at a young age: analysis of patient, tumor and treatment characteristics in Chiang Mai University Hospital. Oral Oncol 2006; 42: 83-8.
23. Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44years. Cancer 2005; 103: 1843-9.
24. Shinghi AD, Westra WH. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer 2010; 116: 2166-73.
25. Bernes L, Eveson JW, Reichart P, Sidransky D, eds. .World Health Organization Classification of Tumors. Pathology and Genetics of Head and Neck Tumors. Lyon: IARC, 2005; 163-208.
26. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. American Joint Committee on Cancer. Cancer Staging Manual, 7th edn. Chicago: Springer Publishers, 2010; 29-40.
27. Lewis JS Jr, Thorstad WL, Chernock RD et al. p16 positive oropharyngeal squamous cell carcinoma: an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol 2010; 34: 1088-96.
28. Chernock RD, El-Mofty SK, Thorstad WL, Parvin CA, Lewis JS Jr. HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome. Head Neck Pathol 2009; 3: 186-94.
29. Begum S, Cao D, Gillison M, Zahurak M, Westra WH. Tissue distribution of humanpapillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 2005; 11: 5694-9.
30. Kim SH, Koo BS, Kang S et al. HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer 2007; 120: 1418-25.
31. McLaughlin-Drubin ME, Munger K. Oncogenic activities of human papillomaviruses. Virus Res 2009; 143: 195-208.
32. Chung CH, Gillison ML. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res 2009; 15: 6758-62.
33. Narisawa-Saito M, Kiyono T. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: role of E6 and E7 proteins. Cancer Sci 2007; 98: 1505-11.
34. Syrjanen S. HPV infections and tonsillar carcinoma. J Clin Pathol 2004; 57: 449-55.
35. Ringstrom E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 2002; 8: 3187-92.
36. Nasman A, Attner P, Hammarstedt L et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 2009; 125: 362-6.
37. Fakhry C, Westra WH, Li S et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-9.
38. Gillison ML, Koch WM, Capone RB et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-20.
39. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 2001; 92: 805-13.
40. Ritchie JM, Smith EM, Summersgill KF et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 2003; 104: 336-44.
41. Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007; 121: 1813-20.
42. Adelstein DJ, Ridge JA, Gillison ML et al. Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C. Head Neck 2009; 31: 1393-422.
43. Goon PK, Stanley MA, Ebmeyer J et al. HPV & head and neck cancer: a descriptive update. Head Neck Oncol 2009; 1: 36.
44. Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 2006; 31: 259-66.
45. Ha PK, Califano JA. The role of human papillomavirus in oral carcinogenesis. Crit Rev Oral Biol Med 2004; 15: 188-96.
46. Takagi H, Itoh M, Islam MZ et al. Sensitive, specific, and rapid detection of Leishmania donovani DNA by loop-mediated isothermal amplification. Am J Trop Med Hyg 2009; 81: 578-82.
47. Notoi T, Okayama H, Masubuchi H et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 2010; 28: E63.
48. Miyagi J, Tsuhako K, Kinjo T, Iwamasa T, Hirayasu T. Recent striking changes in histological differentiation and rate of human papillomavirus infection in squamous cell carcinoma of the lung in Okinawa, a subtropical island in southern Japan. J Clin Pathol 2000; 53: 676-84.
49. Sellors JW, Sankaranarayanan R. Colposcopy and Treatment of Cervical Intraepithelial Neoplasia: A Beginners' Manual. Lyon: IARC, 2003; 21-8.
50. 18F-fluorodeoxyglucose uptake. Cancer 2009; 115: 3548-54.
51. Gillison M, D'Souza G, Westra W et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negatibve head and neck cancers. J Natl Cancer Inst 2008; 100: 407-20.
52. Schwartz SM, Darling JR, Doody DR et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 1998; 90: 1626-36.
53. Smith EM, Rubenstein LM, Hoffman H, Haugen TH, Turek LP. Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer. Infect Agent Cancer 2010; 5: 4.
54. Andl T, Kahn T, Pfuhl A et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 1998; 58: 5-13.
55. Weinberger PM, Yu Z, Haffty BG et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006; 24: 736-47.
56. Strati K, Pitot HC, Lambert PF. Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model. Proc Natl Acad Sci U S A 2006; 103: 14.
57. INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001; 92: 276-84.
58. Klussmann JP, Gultekin E, Weissenborn SJ et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 2003; 162: 747-53.
59. Atual S, Grenman R, Laippala P, Syrjanen S. Cancer of the tongue in patients younger than 40years. Arch Otolaryngol Head Neck Surg 1996; 122: 1313-9.
60. Myers JN, Elkins T, Roberts D, Byers RM. Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg 2000; 122: 44-51.
61. D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009; 199: 1263-9.
62. Nguyen NP, Chi A, Nguyen LM, Ly BH, Karlsson U, Vinh-Hung V. Human papillomavirus-associated oropharyngeal cancer: a new clinical entity. Q J Med 2010; 103: 229-36.